ArticleCritical care (London, England)2010
Inhaled activated protein C protects mice from ventilator-induced lung injury.
Article in Critical care (London, England), 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
19 citing papers in PubMed, 1 synthesis or guideline pooled it, 29 citations in OpenAlex.
- Nebulized anticoagulants for acute lung injury - a systematic review of preclinical and clinical investigations.Critical care (London, England) · 2012Pooled it
- Pharmacotherapy consideration of thrombolytic medications in COVID-19-associated ARDS.Journal of intensive care · 2022Review
- Why translational research matters: proceedings of the third international symposium on acute lung injury translational research (INSPIRES III).Intensive care medicine experimental · 2019Article
- Activated protein C inhibits lung injury induced by LPS via downregulating MAPK signaling.Experimental and therapeutic medicine · 2018Article
- Activated Protein C has No Effect on Pulmonary Capillary Endothelial Function in Septic Patients with Acute Respiratory Distress Syndrome: Association of Endothelial Dysfunction with Mortality.Infectious diseases and therapy · 2018Article
- Anticoagulant therapy in acute respiratory distress syndrome.Annals of translational medicine · 2018Review
- Role of notch signaling pathway in mechanical ventilation induced lung injury.International journal of clinical and experimental pathology · 2017Article
- Inhibition of HMGCoA reductase by simvastatin protects mice from injurious mechanical ventilation.Respiratory research · 2015Article
- Thrombomodulin/activated protein C system in septic disseminated intravascular coagulation.Journal of intensive care · 2015Article
- Acute lung injury and the role of histones.Translational respiratory medicine · 2014Review
- Acute respiratory distress syndrome: prevention and early recognition.Annals of intensive care · 2013Article
- Barrier-protective effects of activated protein C in human alveolar epithelial cells.PloS one · 2013Article
- Metformin attenuates ventilator-induced lung injury.Critical care (London, England) · 2012Article
- Kinetic effects of carbon monoxide inhalation on tissue protection in ventilator-induced lung injury.Laboratory investigation; a journal of technical methods and pathology · 2012Article
- Cytoprotective-selective activated protein C attenuates Pseudomonas aeruginosa-induced lung injury in mice.American journal of respiratory cell and molecular biology · 2011Article
- Activated protein C inhalation: a novel therapeutic strategy for acute lung injury.Medical science monitor : international medical journal of experimental and clinical research · 2011Article
- The pharmacology of acute lung injury in sepsis.Advances in pharmacological sciences · 2011Article
- Year in review 2009: Critical Care--shock.Critical care (London, England) · 2010Review
- Inhaled activated protein C: a new therapy for the prevention of ventilator-induced lung injury?Critical care (London, England) · 2010Article
Corrections and comments
- Commented on by
Authors and funding
10 authors at 4 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionActivated Protein C (APC), an endogenous anticoagulant, improves tissue microperfusion and endothelial cell survival in systemic inflammatory states such as sepsis, but intravenous administration may cause severe bleeding. We have thus addressed the role of APC delivered locally by inhalation in preventing acute lung injury from alveolar overdistention and the subsequent ventilator-induced lung injury (VILI). We also assessed the effects of APC on the activation status of Extracellular- Regulated Kinase 1/2 (ERK) pathway, which has been shown to be involved in regulating pulmonary responses to mechanical stretch.
methodsInhaled APC (12.5 microg drotrecogin-alpha x 4 doses) or saline was given to tracheotomized C57/Bl6 mice starting 20 min prior to initiation of injurious mechanical ventilation with tidal volume 25 mL/Kg for 4 hours and then hourly thereafter; control groups receiving inhaled saline were ventilated with 8 mL/Kg for 30 min or 4 hr. We measured lung function (respiratory system elastance H), arterial blood gases, surrogates of vascular leak (broncho-alveolar lavage (BAL) total protein and angiotensin-converting enzyme (ACE)-activity), and parameters of inflammation (BAL neutrophils and lung tissue myeloperoxidase (MPO) activity). Morphological alterations induced by mechanical ventilation were examined in hematoxylin-eosin lung tissue sections. The activation status of ERK was probed in lung tissue homogenates by immunoblotting and in paraffin sections by immunohistochemistry. The effect of APC on ERK signaling downstream of the thrombin receptor was tested on A549 human lung epithelial cells by immunoblotting. Statistical analyses were performed using ANOVA with appropriate post-hoc testing.
resultsIn mice subjected to VILI without APC, we observed hypoxemia, increased respiratory system elastance and inflammation, assessed by BAL neutrophil counts and tissue MPO activity. BAL total protein levels and ACE activity were also elevated by VILI, indicating compromise of the alveolo-capillary barrier. In addition to preserving lung function, inhaled APC prevented endothelial barrier disruption and attenuated hypoxemia and the inflammatory response. Mechanistically, we found a strong activation of ERK in lung tissues by VILI, which was prevented by APC, suggestive of pathogenetic involvement of the Mitogen-Activated Kinase pathway. In cultured human lung epithelial cells challenged by thrombin, APC abrogated the activation of ERK and its downstream effector, cytosolic Phospholipase A2.
conclusionsTopical application of APC by inhalation may effectively reduce lung injury induced by mechanical ventilation in mice.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.